14.15
price down icon5.07%   -0.6452
 
loading

Transcode Therapeutics Inc (RNAZ) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-06-30 2024-03-31 2023-12-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
33.11%
4.2211
3.1712 5.1139 3.289 4.059
Operating Income/Loss
33.11%
-4.2211
-3.1712 -5.1139 -3.289 -4.059
Nonoperating Income/Loss
99.38%
-0.0554
-8.9142 -0.0769 -0.0378 -0.0285
Income/Loss From Continuing Operations Before Tax
64.61%
-4.2765
-12.09 -5.1908 -3.3268 -4.0875
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
64.61%
-4.2765
-12.09 -5.1908 -3.3268 -4.0875
Net Income/Loss
64.61%
-4.2765
-12.09 -5.1908 -3.3268 -4.0875
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
82.72%
0.8337
4.8233 7.0511 5.1424 -1.5299
Diluted Average Shares
82.72%
0.8337
4.8233 7.0511 5.1424 -1.5299
Basic Earnings Per Share
104.38%
-5.13
-2.51 -0.74 -0.65 -95.15
Diluted Earnings Per Share
104.38%
-5.13
-2.51 -0.74 -0.65 -95.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.77
price up icon 0.43%
$22.76
price down icon 2.66%
$31.84
price down icon 2.86%
$105.78
price down icon 0.48%
$163.51
price up icon 1.09%
biotechnology ONC
$337.29
price down icon 3.95%
자본화:     |  볼륨(24시간):